# The DETOUR 2 Clinical Trial

> **NCT03119233** · NA · COMPLETED · sponsor: **Endologix** · enrollment: 202 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DEVICE:** DETOUR System

## Key facts

- **NCT ID:** NCT03119233
- **Lead sponsor:** Endologix
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-13
- **Primary completion:** 2021-12-22
- **Final completion:** 2023-11-13
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03119233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03119233, "The DETOUR 2 Clinical Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03119233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*